... I-Ticagrelor Chemical Compound Factory ehamba phambili kanye Nomhlinzeki |Jabula-Yethu
isibhengezo_sekhasi

I-Ticagrelor Chemical Compound

I-Ticagrelor Chemical Compound

incazelo emfushane:

Amakhemikhali Nezakhiwo Zomzimba:

Isigaba: Impahla eluhlaza Yezemithi;I-Inhibitor;Amines;Aromatics;Heterocycles;Amakhemikhali Aphakathi & Amahle;Pharmaceutical API.

Isitoreji: Igcinwe esitsheni esipholile futhi esomile esivalwe kahle.Gwema umswakama kanye nokukhanya okunamandla/ukushisa.

  • Ukubukeka :Impushana emhlophe noma emhlophe
  • Isivivinyo:Akukho ngaphansi kuka-99%
  • Ukuminyana:1.7/cm3
  • Indawo yokubilisa:777.6±70.0 °C ku-760 mmHg
  • I-Flash Point::412.6±32.9℃
  • Iphoyinti lokuncibilika:777.6±70.0 °C ku-760 mmHg
  • Imininingwane Yomkhiqizo

    Omaka bomkhiqizo

    Incazelo Yomkhiqizo

    Igama Lomkhiqizo Ticagrelor, CAS NO274693-27-5
    Omqondofana (1S,2S,3R,5S)-3-[7-{[(1R,2S)-2-(3,4-difluorophenyl)cyclopropyl]amino}-5-(propylsulfanyl)-3H-[1,2, 3]i-triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)cyclopentane-1,2-diol;

    (1S,2S,3R,5S)-3-[7-[[(1R,2S)-2-(3,4-difluorophenyl)cyclopropyl]amino]-5-propylsulfanyltriazolo[4,5-d]pyrimidin-3 -yl] -5-(2-hydroxyethoxy)cyclopentane-1,2-diol;

    (1S,2S,3R,5S)-3-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2, 3]i-triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol;

    (1S,2S,3R,5S)-3-[7-{[(1R,2S)-2-(3,4-Difluorophenyl)cyclopropyl]amino}-5-(propylsulfanyl)-3H-[1,2, 3]i-triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy) -1,2-cyclopentanediol;

    (1S,2S,3R,5S)-3-[7-[[(1R,2S)-2-(3,4-D1,2-Cyclopentanediolifluorophenyl)cyclopropyl]amino]-5-(propylthio)-3H-1 ,2,3-triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy) -1,2-cyclopentanediol;I-AR-C 126532XX;I-AZD 6140;

    Inombolo ye-CAS 274693-27-5
    I-Molecular Formula I-C23H28F2N6O4S
    Isisindo samangqamuzana 522.568

    Isicelo

    I-1.Ticagrelor, i-reversible oral P2Y12 receptor antagonist yokuqala, inikeza ukuvinjelwa kwe-ADP-receptor esheshayo, enkulu, futhi ehambisanayo kune-Clopidogrel.Isetshenziswa ekwelapheni ama-acute coronary syndromes (ACS) .s.
    Uma unentshisekelo ngemikhiqizo yethu noma unemibuzo, sicela ukhululeke ukuxhumana nathi!
    Imikhiqizo engaphansi kwelungelo lobunikazi inikezwa inhloso ye-R & D kuphela.

    Izinzuzo Zethu

    1.Isevisi yesampula ephumelelayo nentsha, i-IATF 16946:2016 uhlelo lokulawula ikhwalithi.
    2.Ithimba lesevisi ye-inthanethi elichwepheshile, noma iyiphi i-imeyili noma umlayezo uzophendula engakapheli amahora angama-24.
    3.Sineqembu eliqinile elihlinzeka ngenkonzo yenhliziyo yonke kumakhasimende nganoma yisiphi isikhathi.
    4.Sigcizelela ukuthi iKhasimende Liphakeme, Izisebenzi zibheke Enjabulweni.
    5.Beka Ikhwalithi njengokucatshangelwa kokuqala;
    I-6.OEM & ODM, idizayini eyenziwe ngokwezifiso/ilogo/uphawu nephakheji kwamukelekile.
    I-7.Imishini yokukhiqiza ethuthukisiwe, ukuhlolwa kwekhwalithi eqinile kanye nesistimu yokulawula ukuqinisekisa ikhwalithi ephakeme.
    I-8.Intengo yokuncintisana: singabakhiqizi bezingxenye zezimoto abachwepheshile e-China, ayikho inzuzo ye-middleman, futhi ungathola intengo yokuncintisana kakhulu kithi.
    I-9.Ikhwalithi enhle: ikhwalithi enhle ingaqinisekiswa, izokusiza ukuthi ugcine isabelo semakethe kahle.
    Isikhathi sokulethwa okusheshayo: sinefektri yethu kanye nomkhiqizi ochwepheshe, okusindisa isikhathi sakho sokuxoxa nezinkampani zokuhweba.Sizozama konke okusemandleni ethu ukuhlangabezana nesicelo sakho


  • Okwedlule:
  • Olandelayo: